Skip to content
Recall Observatory FDA recall evidence

Drug product

Lantiseptic, Dry Skin Therapy, Lanolin USP 30%, packaged in a) 5 g (0.17 oz) (NDC 61924-504-05), b) 4 oz (NDC 61924-504-04), and c)14 oz (NDC 61924-710-14) tubes, DermaRite Industries LLC, 7777 West Side Avenue, North Bergen, NJ 07047.

D-0169-2026

August 27, 2025

Class II

Product summary

Firm
DermaRite Industries, LLC
Event
Event 97625
Status
Ongoing
Classification
Class II
Quantity
8,378 containers
Official record key
drug-enforcement:D-0169-2026

Official wording

Reason: CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.

Code information: All lots on or before expiry date 08/2027

Distribution pattern: Nationwide in the USA

Derived failure modes

  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP Deviation

Field note

Send feedback

We'll only use this to respond to your feedback.